NEW YORK, June 12, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Vical Incorporated ("VICL" or the "Company") (NASDAQ: VICL) in connection with the proposed acquisition of the Company by Brickell Biotech, Inc.
If you are a shareholder of VICL who wishes to discuss the investigation or have any questions about this notice and your rights or interests, please contact:
Joshua Rubin, Esq.
1500 Broadway, 16th Floor
New York, NY 10036
Or visit our website
Or follow us on Twitter @MarketsAlert
WeissLaw is investigating whether VICL's Board acted to maximize shareholder value prior to entering into the agreement. Notably, at close of the transaction, VICL shareholders will own only 40% of the combined company.
WeissLaw is also investigating whether VICL's Board conducted a fair process in agreeing to the proposed merger, whether the proposed merger undervalues the Company, and whether all material information related to the proposed merger is fully and fairly disclosed.
WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at firstname.lastname@example.org
SOURCE WeissLaw LLP